This article was originally published by the National Organization for the Reform of Marijuana Laws (NORML) and appears here with permission.
Nearly a quarter of Canadian cancer survivors acknowledge consuming cannabis as a sleep aid, according to data published in the Journal of Cancer Survivorship: Research and Practice.
Investigators surveyed over 1,400 cancer survivors. Twenty-four percent of respondents said that they used cannabis prior to bedtime, “with reported benefits including relaxation, reduced time to fall asleep, fewer nocturnal awakenings and improved sleep quality.” (Cannabis is legal for both medical and adult use in Canada.)
Over two-thirds of consumers said that they initiated cannabis use following their cancer diagnosis. Over one-third of consumers said that they used marijuana daily.
Adults frequently report using cannabis and CBD products as sleep aids. Data published in the journal Complementary Therapies in Medicine reported that the enactment of adult-use marijuana legalization laws is associated with a significant reduction in the sales of over-the-counter sleep aids among the general public.
Full text of the survey, “A cross-sectional survey of the prevalence and patterns of using cannabis as a sleep aid in Canadian cancer survivors,” appears in the Journal of Cancer Survivorship: Research and Practice.
Photo by Roxana Gonzalez on Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.